Breast Cancer
News
FDA panel votes against 2 cancer indications but backs 4 of 6
At a 3-day meeting, an FDA advisory group considered the accelerated approvals of six cancer indications for three immunotherapies.
News
AHA statement flags CV risk of hormonal cancer therapies
The American Heart Association outlines cardiovascular risks associated with hormonal therapies for breast and prostate cancer and provides...
News
FDA panel backs atezolizumab for mTNBC – at least for now
FDA advisers voted to keep in place an approval for atezolizumab in metastatic triple-negative breast cancer.
Conference Coverage
Cell-free DNA improves response prediction in breast cancer
Using cell-free DNA and MRI in combination improved prediction of pathological complete response.
News
Quicker fertility rebound in young women with breast cancer
Phase 3 results support omitting cyclophosphamide from standard chemotherapy.
Conference Coverage
Personalized cancer vaccine shows early promise across tumor types
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
News
Rankings of most common cancers to shift over next 20 years
“It’s time to shift focus to some of the less commonly diagnosed cancers with the lowest survival rates, like pancreatic and liver cancer.”
Article
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Article
Cancer screening stopped by pandemic: Repercussions to come?
Article
Treating metastatic TNBC: Where are we now?